| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
PURPOSE. To determine whether corneal tissue as an allograft displays immune privilege in a nonprivileged site and, if so, whether CD95 ligand expression contributes to the privileged status.
METHODS. Syngeneic and allogeneic corneal tissues deprived of epithelium were transplanted beneath the kidney capsule of normal mice. Syngeneic BALB/c, allogeneic C57BL/6, and allogeneic B6Smn.C3H-gld (CD95 ligand–deficient) mice were used as donors for BALB/c recipients, and syngeneic C3H/HeJ-gld (CD95 ligand–deficient) mice were used for normal C3H/HeJ recipients. Allogeneic conjunctival segments served as positive grafting controls. Graft fate was assessed by visual inspection at 4, 7, 14, and 21 days and was confirmed by histologic study. Viability of graft endothelium was assessed by immunocytochemical analysis.
RESULTS. Syngeneic corneas and C57BL/6 corneas survived almost indefinitely beneath the kidney capsule. Both the stroma and the endothelial layers remained healthy and intact. Allogeneic conjunctiva evoked a strong inflammatory response attended by neovascularization. Similarly, B6-gld corneas deficient in CD95 ligand expression showed acute destruction beneath the kidney capsule. Circumstantial evidence implicates alloimmune rejection as the mechanism.
CONCLUSIONS. Epithelium-deprived corneas from normal mice possess inherent immune privilege that protects them from alloimmune rejection even at nonprivileged sites. Constitutive expression of CD95 ligand contributes to the privileged status. It is inferred that the extraordinary success of orthotopic corneal allografts owes as much to the qualities of the graft as an immune-privileged tissue as to the qualities of the eye as an immune-privileged site.
This article has been cited by other articles:
|
|
 |
|
  J. Hori, M. Wang, M. Miyashita, K. Tanemoto, H. Takahashi, T. Takemori, K. Okumura, H. Yagita, and M. Azuma B7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts J. Immunol., November 1, 2006; 177(9): 5928 - 5935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Osawa, K. Maruyama, and J. W. Streilein CD95 Ligand Expression on Corneal Epithelium and Endothelium Influences the Fates of Orthotopic and Heterotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1908 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zamiri, Q. Zhang, and J. W. Streilein Vulnerability of Allogeneic Retinal Pigment Epithelium to Immune T-Cell-Mediated Damage In Vivo and In Vitro Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Streilein Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation J. Leukoc. Biol., August 1, 2003; 74(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Hori, T. F. Ng, M. Shatos, H. Klassen, J. W. Streilein, and M. J. Young Neural Progenitor Cells Lack Immunogenicity and Resist Destruction as Allografts Stem Cells, July 1, 2003; 21(4): 405 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Gipson, S. Spurr-Michaud, P. Argueso, A. Tisdale, T. F. Ng, and C. L. Russo Mucin Gene Expression in Immortalized Human Corneal-Limbal and Conjunctival Epithelial Cell Lines Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2496 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hori and J. W. Streilein Survival in High-Risk Eyes of Epithelium-Deprived Orthotopic Corneal Allografts Reconstituted In Vitro with Syngeneic Epithelium Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Higuchi and J. W. Streilein CD8+ T Cell-Mediated Delayed Rejection of Orthotopic Guinea Pig Cornea Grafts in Mice Deficient in CD4+ T Cells Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 175 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Ng, H. Osawa, J. Hori, M. J. Young, and J. W. Streilein Allogeneic Neonatal Neuronal Retina Grafts Display Partial Immune Privilege in the Subcapsular Space of the Kidney J. Immunol., November 15, 2002; 169(10): 5601 - 5606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hori and J. W. Streilein Dynamics of Donor Cell Persistence and Recipient Cell Replacement in Orthotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1820 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kubo, Y. Sonoda, R. Muramatsu, and M. Usui Immunogenicity of Human Amniotic Membrane in Experimental Xenotransplantation Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1539 - 1546. [Abstract] [Full Text]
|
|
|
|
|
|
J. Hori and J. W. Streilein Role of Recipient Epithelium in Promoting Survival of Orthotopic Corneal Allografts in Mice Invest. Ophthalmol. Vis. Sci., March 1, 2001; 42(3): 720 - 726. [Abstract] [Full Text]
|
|
|
|
|
|
J. Hori, N. C. Joyce, and J. W. Streilein Immune Privilege and Immunogenicity Reside among Different Layers of the Mouse Cornea Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3032 - 3042. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Sano, B. R. Ksander, and J. W. Streilein Langerhans Cells, Orthotopic Corneal Allografts, and Direct and Indirect Pathways of T-Cell Allorecognition Invest. Ophthalmol. Vis. Sci., May 1, 2000; 41(6): 1422 - 1431. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
